iSpecimen (ISPC) Cash from Investing Activities Growth (3y) (2023 - 2026)
iSpecimen (ISPC) Cash from Investing Activities Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -41.81% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 5.49% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 5.31% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -59.07% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 0.00% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 4.07% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -86.97% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -11.88% |
| 10 | iSpecimen | 931,959.22 | -1.89 Mn | -1.39 Mn | 56.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56.97% |
| Sep 30, 2025 | -9.00% |
| Dec 31, 2024 | 37.84% |
| Sep 30, 2024 | 14.79% |
| Jun 30, 2024 | 48.77% |
| Mar 31, 2024 | 122.61% |
| Dec 31, 2023 | -45.10% |
| Sep 30, 2023 | 119.55% |